Lactylation enzymes in cancer: Mechanisms and novel therapeutic approaches (Review)
Oncology Letters · 02.04.2026 · 31 (6) · 1-27
DOI: 10.3892/ol.2026.15572 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Letters, online erschienen am 02.04.2026. Verfasst von Guiyang Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Medicine, School of Basic Medical, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Metabolic reprogramming, particularly the Warburg effect, drives tumor progression not only by supplying energy but also by reshaping the epigenetic landscape through lysine lactylation. The present review summarizes the molecular organization of the lactylation regulatory network, highlighting two distinct writer mechanisms: i) A classical acyl-coenzyme A (acyl-CoA)-dependent pathway mediated by the MYST (MOZ, Ybf2/Sas3, Sas2 and Tip60) family; and ii) a recently described acyl-CoA-independent pathway driven by the metabolic sensors, alanyl-tRNA synthetases 1 and 2. The present review further explains how these 'writers', together with specific 'erasers' and 'readers', convert intracellular lactate accumulation into stable transcriptional programs that support immunosuppression, metabolic plasticity and therapeutic resistance. In addition, the current review discusses emerging therapeutic strategies targeting this axis, shifting from broad lactate metabolism inhibition towards more precise approaches that reduce the off-target toxicity of conventional epigenetic drugs. Finally, the present review outlines lactylation-associated gene signatures as potential biomarkers, providing a framework for the development of metabolic-epigenetic therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Translational Medicine, School of Basic Medical, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China.
- Medical College, Hunan University of Chinese Medicine, Changsha, Hunan 410208, P.R. China.
- The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421002, P.R. China.
- Department of Oncology, The Third Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421900, P.R. China.
Zitieren
APA
Tang, G., Zuo, H., Long, R., Zhang, C., Lv, Y., Luo, X., Qiu, J., & Zuo, J. (2026). Lactylation enzymes in cancer: Mechanisms and novel therapeutic approaches (Review). Oncology Letters, 31(6), 1-27. https://doi.org/10.3892/ol.2026.15572
Vancouver
Tang G, Zuo H, Long R, Zhang C, Lv Y, Luo X, et al. Lactylation enzymes in cancer: Mechanisms and novel therapeutic approaches (Review). Oncology Letters. 2026;31(6):1-27. doi:10.3892/ol.2026.15572
BibTeX
@article{Tang2026,
author = {Tang, Guiyang and Zuo, Hanrong and Long, Rou and Zhang, Chaohui and Lv, Yufan and Luo, Xinyu and Qiu, Jieya and Zuo, Jianhong},
title = {Lactylation enzymes in cancer: Mechanisms and novel therapeutic approaches (Review)},
journal = {Oncology Letters},
year = {2026},
volume = {31},
number = {6},
pages = {1--27},
doi = {10.3892/ol.2026.15572}
}
EUVIMED